Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Transcutaneous nitroglycerin evaluated in controlled trial for MED

March 9, 1999

Fluvastatin induces delayed improvement in coronary flow reserve

March 9, 1999

Hemosol successfully completes phase II trial of Hemolink in CABG patients

March 8, 1999

Rhone-Poulenc Rorer describes new hypoglycemic series

March 5, 1999

Lilly's recombinant glucagon now being launched, will replace animal-derived product

March 4, 1999

AC-2993 advances to clinical trials in type II diabetes

March 4, 1999

Preclinical results obtained with candidate antidiabetic support further testing

March 3, 1999

Vitronectin receptor antagonists with a benzocycloheptene core designed at SB

March 3, 1999

Novel vitamin D compounds with favorable biological profile from WARF

March 3, 1999

Novel hypoglycemic compounds designed at RPR

March 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...